CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Prestige Consumer Healthcare Inc.  (PBH)
Other Ticker:  
 
 

PBH's Net Income Growth by Quarter and Year

Prestige Consumer Healthcare's Net Income results by quarter and year




PBH Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter March - -146.65 11.09 13.94
III Quarter December 89.16 372.43 31.64 28.00
II Quarter September 74.36 80.03 32.20 31.80
I Quarter June 80.93 33.76 -5.53 26.17
FY   244.45 339.57 69.40 99.91



PBH Net Income third quarter 2019 Y/Y Growth Comment
Prestige Consumer Healthcare Inc. reported drop in Net Income in the third quarter by -76.06% to $ 89.16 millions, from the same quarter in 2018.
The fall in the third quarter Prestige Consumer Healthcare Inc.'s Net Income compares unfavorably to the Company's average Net Income increase of 10.94%.

Looking into third quarter results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Net Income growth. While Prestige Consumer Healthcare Inc.' s Net Income meltdown of -76.06% ranks overall at the positon no. 468 in the third quarter.




PBH Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter March - - -20.44 % -41.35 %
III Quarter December -76.06 % 1077.09 % 13 % 31.52 %
II Quarter September -7.08 % 148.54 % 1.26 % 93.2 %
I Quarter June 139.72 % - - 56.43 %
FY   - 389.29 % -30.54 % -

Financial Statements
Prestige Consumer Healthcare's third quarter 2019 Net Income $ 89.16 millions PBH's Income Statement
Prestige Consumer Healthcare's third quarter 2018 Net Income $ 372.43 millions Quarterly PBH's Income Statement
New: More PBH's historic Net Income Growth >>


PBH Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter March - - -64.95 % -50.21 %
III Quarter December 19.91 % 365.36 % -1.74 % -11.95 %
II Quarter September -8.12 % 137.06 % - 21.51 %
I Quarter June - 204.42 % - 10.1 %
FY (Year on Year)   - 389.29 % -30.54 % -




Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #41
Overall #468

Net Income Y/Y Growth Statistics
High Average Low
217.74 % 10.94 % -74.33 %
(Dec 31 2017)   (Dec 31 2018)
Net Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #41
Overall #468
Net Income Y/Y Growth Statistics
High Average Low
217.74 % 10.94 % -74.33 %
(Dec 31 2017)   (Dec 31 2018)

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Prestige Consumer Healthcare's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
411.21 % 50.2 % -90.45 %
(Mar 31 2014)  


PBH's III. Quarter Q/Q Net Income Comment
Prestige Consumer Healthcare Inc. achieved in the III. Quarter 2019 below company average Net Income jump of 19.91% quarter on quarter, to $ 89.16 millions.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Net Income quarter on quarter growth. While Prestige Consumer Healthcare's Net Income growth quarter on quarter, overall rank is 142.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #10
Overall #142
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #10
Overall #142
Net Income Q/Q Growth Statistics
High Average Low
411.21 % 50.2 % -90.45 %
(Mar 31 2014)  


PBH's III. Quarter Q/Q Net Income Comment
Prestige Consumer Healthcare Inc. achieved in the III. Quarter 2019 below company average Net Income jump of 19.91% quarter on quarter, to $ 89.16 millions.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Net Income quarter on quarter growth. While Prestige Consumer Healthcare's Net Income growth quarter on quarter, overall rank is 142.


Prestige Consumer Healthcare's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
Cumulative Net Income 12 Months Ending $ 97.80 $ 381.07 $ 386.74 $ 339.57 $ 497.31
Y / Y Net Income Growth (TTM) -80.33 % 143.47 % 255.83 % 389.33 % 588.4 %
Year on Year Net Income Growth Overall Ranking # 428 # 114 # 144 # 91 # 8
Seqeuential Net Income Change (TTM) -74.33 % -1.47 % 13.89 % -31.72 % 217.74 %
Seq. Net Income Growth (TTM) Overall Ranking # 468 # 709 # 662 # 2173 # 9




Cumulative Net Income growth Comment
For the 12 months ended Dec 31 2018 Prestige Consumer Healthcare reported a sharp drop in Net Income by -80.33% year on year, to $98 millions, compare to the 143.47% growth at Sep 30 2018.

Within the Healthcare sector 33 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 114 to 428.

Net Income TTM Q/Q Growth Statistics
High Average Low
217.74 %
10.94 %
-74.33 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 34
Overall # 428

Net Income TTM Y/Y Growth Statistics
High Average Low
588.4 %
77.04 %
-80.33 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 41
S&P 500 # 468
Cumulative Net Income growth Comment
For the 12 months ended Dec 31 2018 Prestige Consumer Healthcare reported a sharp drop in Net Income by -80.33% year on year, to $98 millions, compare to the 143.47% growth at Sep 30 2018.

Within the Healthcare sector 33 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 114 to 428.

Net Income TTM Q/Q Growth Statistics
High Average Low
217.74 %
10.94 %
-74.33 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 34
Overall # 428

Net Income TTM Y/Y Growth Statistics
High Average Low
588.4 %
77.04 %
-80.33 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 41
S&P 500 # 468




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PBH's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PBH's Competitors
Net Income Growth for Prestige Consumer Healthcare's Suppliers
Net Income Growth for PBH's Customers

You may also want to know
PBH's Annual Growth Rates PBH's Profitability Ratios PBH's Asset Turnover Ratio PBH's Dividend Growth
PBH's Roe PBH's Valuation Ratios PBH's Financial Strength Ratios PBH's Dividend Payout Ratio
PBH's Roa PBH's Inventory Turnover Ratio PBH's Growth Rates PBH's Dividend Comparisons



Companies with similar Net Income sharp drop for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2018
Fonar Corp -7.18 %$ -7.176 millions
Lannett Co Inc -11.84 %$ -11.839 millions
Petmed Express Inc -14.09 %$ -14.089 millions
Coherent Inc -15.16 %$ -15.157 millions
Quest Diagnostics Inc -47.94 %$ -47.940 millions
Nuvasive Inc -48.32 %$ -48.321 millions
Steris Plc -49.21 %$ -49.207 millions
Hill-rom Holdings, Inc. -52.21 %$ -52.208 millions
Mednax, Inc. -55.76 %$ -55.759 millions
Bio-techne Corp -64.06 %$ -64.059 millions
Cyanotech Corp -73.98 %$ -73.984 millions
Hologic Inc -75.76 %$ -75.756 millions
Prestige Consumer Healthcare Inc. -76.06 %$ -76.059 millions
Shineco, Inc. -79.29 %$ -79.290 millions
Myriad Genetics Inc -91.90 %$ -91.900 millions
Cambrex Corp -96.99 %$ -96.989 millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NYLD's Profile

Stock Price

NYLD's Financials

Business Description

Fundamentals

Charts & Quotes

NYLD's News

Suppliers

NYLD's Competitors

Customers & Markets

Economic Indicators

NYLD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071